Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$727K Buy
6,409
+924
+17% +$91.6K 0.03% 471
2026
Q1
$516K Buy
5,485
+171
+3% +$17.1K 0.03% 542
2025
Q4
$525K Buy
5,314
+314
+6% +$30.4K 0.03% 546
2025
Q3
$424K Buy
5,000
+605
+14% +$47.8K 0.02% 553
2025
Q2
$299K Sell
4,395
-496
-10% -$31.4K 0.02% 546
2025
Q1
$296K Sell
4,891
-101
-2% -$7.04K 0.02% 432
2024
Q4
$345K Buy
4,992
+1,015
+26% +$72.3K 0.03% 368
2024
Q3
$263K Sell
3,977
-36
-0.9% -$2.3K 0.02% 389
2024
Q2
$243K Buy
4,013
+39
+1% +$2.21K 0.02% 391
2024
Q1
$226K Buy
3,974
+109
+3% +$6.54K 0.02% 408
2023
Q4
$243K Buy
+3,865
New +$219K 0.02% 389

Other funds holding INCY

Syon Capital's INCY Position: Q2 2026 in Review

Syon Capital increased its Incyte (INCY) stake by 17% in Q2 2026, buying an estimated $91.6K and bringing the position to 6,409 shares worth $727K. The position accounts for 0.03% of the portfolio, ranked #471.

Syon Capital first reported a position in INCY in Q4 2023 and has held it in 11 quarters since. 858 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Syon Capital held 6,409 shares of Incyte worth $727K as of Q2 2026.
  • Syon Capital bought 924 Incyte shares in Q2 2026, an estimated $91.6K.
  • Incyte made up 0.03% of Syon Capital's portfolio in Q2 2026, its #471 holding.
  • Syon Capital first reported a position in Incyte in Q4 2023 and has held it in 11 quarters since.
  • 858 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.